Adamis Pharmaceuticals
David C. Benedicto was named Chief Financial Officer in August 2021. Prior to this, Benedicto served as Chief Accounting Officer since May 2021.
Adamis Pharmaceuticals
Adamis Pharmaceuticals Corporation is a specialty biopharmaceutical company focused on developing and commercializing pharmaceutical products in various therapeutic areas, including respiratory disease, allergy and opioid overdose.